Company / PP&E per Share
X4 Pharmaceuticals, Inc PP&E per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.00 / $0.09
FY2021-FY2025
Trend
+589.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share changed +589% YoY in FY2025, a notable deviation from the 5-year average annual change of +150%.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -16.1%.
Declined from $0.04 to $0.03 over the past 3 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -16.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share increased 589.2% year-over-year.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +589.2% |
| FY2024 | $0.00 | -88.2% |
| FY2022 | $0.04 | -57.7% |
| FY2021 | $0.09 | +21.1% |
| FY2020 | $0.08 | +284.7% |
| FY2018 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026